Release Date: 20/12/10 16:43 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 96.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%